(36B5) iShares MSCI EM SRI USD - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BGDQ0T50
36B5: Equity, Stocks, Emerging Markets, Shares, Global
The iShares MSCI EM SRI UCITS ETF USD (Dist) (XETRA: 36B5) is a UCITS-compliant exchange-traded fund designed to track the performance of the Morningstar EM TME NR USD Index. This index focuses on emerging market equities that meet specific sustainability criteria, emphasizing companies with strong environmental, social, and governance (ESG) practices. The fund is managed by BlackRock and provides investors with exposure to a diversified portfolio of emerging market stocks.
Ticker Symbol: 36B5 | Exchange: XETRA | Type: ETF | Country Origin: Germany | ETF Category: Global Emerging Markets Equity
From a technical perspective, the ETF shows a short-term trend slightly below its 20-day simple moving average (SMA) of 4.42, with a last price of 4.45. The 50-day SMA stands at 4.67, while the 200-day SMA is at 4.79, indicating a recent downtrend. The Average True Range (ATR) of 0.09 suggests relatively low volatility, while the 20-day average volume of 57,056 indicates moderate liquidity.
Fundamentally, the ETF has a sizable asset base of 3.59745 billion EUR, reflecting strong investor interest in ESG-focused emerging market exposure. The funds large AUM typically translates to lower expense ratios and tighter bid-ask spreads compared to smaller ETFs in the same category. The portfolio is diversified across key emerging markets, with a focus on sectors and companies aligned with sustainability principles.
3-Month Forecast: Based on
Additional Sources for 36B5 ETF
36B5 ETF Overview
Market Cap in USD | 4,042m |
Category | Global Emerging Markets Equity |
TER | 0.25% |
IPO / Inception | 2018-12-06 |
36B5 ETF Ratings
Growth Rating | 12.2 |
Fundamental | - |
Dividend Rating | 47.1 |
Rel. Strength | -16.1 |
Analysts | - |
Fair Price Momentum | 4.83 EUR |
Fair Price DCF | - |
36B5 Dividends
Dividend Yield 12m | 2.23% |
Yield on Cost 5y | 2.91% |
Annual Growth 5y | 4.78% |
Payout Consistency | 94.0% |
Payout Ratio | % |
36B5 Growth Ratios
Growth Correlation 3m | 28.6% |
Growth Correlation 12m | 24% |
Growth Correlation 5y | -12.5% |
CAGR 5y | 5.33% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.06 |
Alpha | -0.62 |
Beta | 0.645 |
Volatility | 14.28% |
Current Volume | 249.4k |
Average Volume 20d | 25.7k |
As of June 01, 2025, the stock is trading at EUR 4.78 with a total of 249,353 shares traded.
Over the past week, the price has changed by -1.36%, over one month by +6.22%, over three months by -4.21% and over the past year by +8.26%.
Neither. Based on ValueRay´s Analyses, iShares MSCI EM SRI USD is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.20 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 36B5 is around 4.83 EUR . This means that 36B5 is currently overvalued and has a potential downside of 1.05%.
iShares MSCI EM SRI USD has no consensus analysts rating.
According to our own proprietary Forecast Model, 36B5 iShares MSCI EM SRI USD will be worth about 5.5 in June 2026. The stock is currently trading at 4.78. This means that the stock has a potential upside of +14.85%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 5.5 | 14.9% |